Arsenic trioxide
Trisenox (arsenic trioxide) is a small molecule pharmaceutical. Arsenic trioxide was first approved as Trisenox on 2000-09-25. It is used to treat promyelocytic leukemia acute in the USA. It has been approved in Europe to treat promyelocytic leukemia acute.
| Trade Name | Trisenox |
|---|---|
| Common Name | Arsenic trioxide |
| Indication | promyelocytic leukemia acute |
| Drug Class | Antineoplastic agent |
